New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine
- The shot, named mFlusiva, is intended for adults age 50 or older
- Flu vaccines must be updated annually to best match circulating strains of the virus
US Food and Drug Administration
